These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25285802)

  • 1. Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY.
    Gupta N; Choudhary D; Sharma SK; Khandelwal V; Dhamija M
    Bone Marrow Transplant; 2015 Jan; 50(1):155-6. PubMed ID: 25285802
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment strategy for acquired aplastic anemia].
    Yamazaki H
    Rinsho Ketsueki; 2018; 59(10):1969-1978. PubMed ID: 30305499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.
    Esteves I; Bonfim C; Pasquini R; Funke V; Pereira NF; Rocha V; Novis Y; Arrais C; Colturato V; de Souza MP; Torres M; Fernandes JF; Kerbauy FR; Ribeiro AA; Santos FP; Hamerschlak N
    Bone Marrow Transplant; 2015 May; 50(5):685-9. PubMed ID: 25730184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of aplastic anemia in children].
    Kojima S
    Rinsho Ketsueki; 2014 Oct; 55(10):1769-76. PubMed ID: 25297739
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of acquired a plastic anemia: an update].
    Kojima S
    Rinsho Ketsueki; 2004 Mar; 45(3):202-8. PubMed ID: 15103933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hematopoietic stem cell transplantation for acquired aplastic anemia].
    Yamazaki H
    Rinsho Ketsueki; 2015 Oct; 56(10):2153-9. PubMed ID: 26458455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good outcome of haploidentical hematopoietic SCT as a salvage therapy in children and adolescents with acquired severe aplastic anemia.
    Wang Z; Zheng X; Yan H; Li D; Wang H
    Bone Marrow Transplant; 2014 Dec; 49(12):1481-5. PubMed ID: 25133891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
    Sorror ML; Leisenring W; Deeg HJ; Martin PJ; Storb R
    Biol Blood Marrow Transplant; 2005 Jul; 11(7):567-8. PubMed ID: 15983557
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcome of Fludarabine-Based Conditioning in High-Risk Aplastic Anemia Patients Undergoing Matched Related Donor Transplantation: A Single-Center Study from Pakistan.
    Chaudhry QUN; Iftikhar R; Satti TM; Mahmood SK; Ghafoor T; Shamshad GU; Farhan M; Shahbaz N; Khan MA; Khattak TA; Rehman J; Humayun S; Satti HS; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2375-2382. PubMed ID: 31394274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Haploidentical Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy for the Treatment of Acquired Severe Aplastic Anemia in Pediatric Patients.
    Zhang Y; Guo Z; Liu XD; He XP; Yang K; Chen P; Chen HR
    Am J Ther; 2017; 24(2):e196-e201. PubMed ID: 26872138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling.
    Mori T; Koh H; Onishi Y; Kako S; Onizuka M; Kanamori H; Ozawa Y; Kato C; Iida H; Suzuki R; Ichinohe T; Kanda Y; Maeda T; Nakao S; Yamazaki H
    Int J Hematol; 2016 Apr; 103(4):461-8. PubMed ID: 26910242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Agent Cyclosporine for Graft-versus-Host Disease Prophylaxis in Patients with Acquired Aplastic Anemia Receiving Fludarabine-Based Conditioning.
    Iftikhar R; Chaudhry QUN; Mahmood SK; Ghafoor T; Satti HS; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Humayun S; Risalat A; Wahab A; Satti TM; Anwer F; Ahmed P
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2245-2251. PubMed ID: 32717437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
    Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
    J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progresses in studies on allogeneic hematopoietic stem cell transplantation in children with acquired severe aplastic anemia].
    Liu TF; Zhu XF
    Zhonghua Er Ke Za Zhi; 2013 May; 51(5):345-8. PubMed ID: 23941840
    [No Abstract]   [Full Text] [Related]  

  • 16. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
    Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
    J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early administration of cyclosporine may reduce the incidence of cytokine release syndrome after HLA-haploidentical hematopoietic stem-cell transplantation with post-transplant cyclophosphamide.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Ann Hematol; 2021 May; 100(5):1295-1301. PubMed ID: 33580280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
    George B; Pn N; Devasia AJ; Kulkarni U; Korula A; Lakshmi KM; Abraham A; Srivastava A; Mathews V
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):494-500. PubMed ID: 29100905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Outcome of Unrelated Hematopoietic Stem Cell Transplants with Total Body Irradiation (800 cGy) and Cyclophosphamide (120 mg/kg) in Adult Patients with Acquired Severe Aplastic Anemia.
    Lee JW; Cho BS; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Min WS; Park CW
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):101-8. PubMed ID: 20601037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.